Glutamate mediated signaling in the pathophysiology of autism spectrum disorders

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 4, 2012, Pages 841-849

  Choudhury, Paromita Roy ^a   Lahiri, Sanjukta ^a   Rajamma, Usha ^a  

^a Manovikas Kendra Rehabilitation and Research Institute for the Handicapped   (India)

Author keywords

Autism spectrum disorder (ASD); Glutamate; Neurotransmitter; Pathology; Signaling; Therapeutic interventions

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; AMPA RECEPTOR; ASPARTIC ACID; DOPAMINE; EXCITATORY AMINO ACID TRANSPORTER; G PROTEIN COUPLED RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GLYCINE; LAMOTRIGINE; MEMANTINE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; NEUROTENSIN; NORADRENALIN; PLACEBO; REGULATOR PROTEIN; SEROTONIN; SOMATOSTATIN; VASOPRESSIN; VESICULAR GLUTAMATE TRANSPORTER 1;

AUTISM; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CELL INTERACTION; CEREBELLUM; CHILD; CHILD BEHAVIOR CHECKLIST; CHROMOSOME 2Q; CHROMOSOME 7Q; FRAGILE X SYNDROME; GABAERGIC SYSTEM; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; INTRACELLULAR SIGNALING; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL DIFFERENTIATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOCIALIZATION;

CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; GLUTAMIC ACID; HUMANS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84855528326     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.023     Document Type: Review

References (149)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM IV, 4th edition Washington, DC: American Psychiatric Association; 1994.
2. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008;9:341-55. (Pubitemid 351556064)
3. Aldred S, Moore KM, Fitzgerald M, Waring RH. Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 2003;33:93-7. (Pubitemid 36323144)
4. Allen G, Courchesne E. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry 2003;160:262-73. (Pubitemid 41110451)
5. Arango V, Huang YY, Underwood MD, Mann JJ. Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 2003;37:375-86. (Pubitemid 36808811)
6. Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci 2005;23:189-99. (Pubitemid 40313552)
7. Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999;53:2145-50.
8. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain 1998;121(Pt 5):889-905. (Pubitemid 28220896)
9. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006;98:641-53. (Pubitemid 44051266)
10. Bannerman DM, Deacon RM, Brady S, Bruce A, Sprengel R, Seeburg PH, et al. A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors. Behav Neurosci 2004;118:643-7. (Pubitemid 38685333)
11. Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, et al. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am J Hum Genet 2005;76:950-66. (Pubitemid 40705432)
12. Bauman M, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology 1985;35:866-74. (Pubitemid 15025292)
13. Belsito KM, Law PA, Kirk KS, Landa RJ, Zimmerman AW. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord 2001;31:175-81. (Pubitemid 37490163)
14. Benayed R, Gharani N, Rossman I, Mancuso V, Lazar G, Kamdar S, et al. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am J Hum Genet 2005;77:851-68. (Pubitemid 41513285)
15. Blandini F. An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease. Funct Neurol 2010;25:65-71.
16. Blasi F, Bacchelli E, Carone S, Toma C, Monaco AP, Bailey AJ, et al. SLC25A12 and CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family sample. Eur J Hum Genet 2006;14:123-6. (Pubitemid 43019093)
17. Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 2001;31:537-43. (Pubitemid 37490148)
18. Blaylock RL, Strunecka A. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. Curr Med Chem 2009;16:157-70.
19. Breese CR, Logel J, Adams C, Leonard SS. Regional gene expression of the glutamate receptor subtypes GluR1, GluR2, and GluR3 in human postmortem brain. J Mol Neurosci 1996;7:277-89. (Pubitemid 126718467)
20. Brune CW, Kim SJ, Hanna GL, Courchesne E, Lord C, Leventhal BL, et al. Family-based association testing of OCD-associated SNPs of SLC1A1 in an autism sample. Autism Res 2008;1:108-13.
21. Bu DF, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci U S A 1992;89:2115-9.
22. Burgess NK, Sweeten TL, McMahon WM, Fujinami RS. Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord 2006;36:697-704. (Pubitemid 44336992)
23. Cadet JL, Jayanthi S, McCoy MT, Beauvais G, Cai NS. Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration. CNS Neurol Disord Drug Targets 2010;9:526-38.
24. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A 2006;103:16834-9. (Pubitemid 44737339)
25. Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. J Neural Transm 1998;105:525-35. (Pubitemid 28365035)
26. Cartmell J, Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 2000;75:889-907. (Pubitemid 30660476)
27. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093-9. (Pubitemid 32578206)
28. Chapman AG, Nanan K, Williams M, Meldrum BS. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 2000;39:1567-74. (Pubitemid 30330873)
29. Chez MG, Burton Q, Dowling T, Chang M, Khanna P, Kramer C. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 2007;22:574-9. (Pubitemid 46951501)
30. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37. (Pubitemid 27238875)
31. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, et al. Brief report: high frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 2006;36:1137-40. (Pubitemid 46020366)
32. del Arco A, Satrustegui J. Molecular cloning of Aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. J Biol Chem 1998;273:23327-34. (Pubitemid 28417520)
33. Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 2007;8:101-13. (Pubitemid 46151040)
34. Devlin B, Cook Jr EH, Coon H, Dawson G, Grigorenko EL, McMahon W, et al. Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 2005;10:1110-6. (Pubitemid 43251101)
35. Dolen G, Bear MF. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol 2008;586:1503-8. (Pubitemid 351404955)
36. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al. Correction of fragile X syndrome in mice. Neuron 2007;56:955-62. (Pubitemid 350251119)
37. Dutta S, Das S, Guhathakurta S, Sen B, Sinha S, Chatterjee A, et al. Glutamate receptor 6 gene (GluR6 or GRIK2) polymorphisms in the Indian population: a genetic association study on autism spectrum disorder. Cell Mol Neurobiol 2007;27:1035-47. (Pubitemid 351170069)
38. Elias GM, Elias LA, Apostolides PF, Kriegstein AR, Nicoll RA. Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development. Proc Natl Acad Sci U S A 2008;105:20953-8.
39. Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron 1991;7:91-100.
40. Fatemi SH. The hyperglutamatergic hypothesis of autism. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:911. author reply 912-3.
41. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 2002;52:805-10.
42. Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res 2006;326:483-504. (Pubitemid 44435821)
43. Filipek PA, Juranek J, Smith M, Mays LZ, Ramos ER, Bocian M, et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol 2003;53:801-4. (Pubitemid 36622519)
44. Fombonne E. Epidemiological trends in rates of autism. Mol Psychiatry 2002;7(Suppl 2):S4-6.
45. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365-82. (Pubitemid 37127933)
46. Francis PT. Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 2003;18:S15-21. (Pubitemid 37150474)
47. Furuta A, Martin LJ, Lin CL, Dykes-Hoberg M, Rothstein JD. Cellular and synaptic localization of the neuronal glutamate transporters excitatory amino acid transporter 3 and 4. Neuroscience 1997;81:1031-42.
48. Gadow KD, Roohi J, DeVincent CJ, Kirsch S, Hatchwell E. Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder. J Autism Dev Disord 2010;40:1139-45.
49. Gajcy K, Lochynski S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Curr Med Chem 2010;17:2338-47.
50. Ge Y, Dong Z, Bagot RC, Howland JG, Phillips AG, Wong TP, et al. Hippocampal long-term depression is required for the consolidation of spatial memory. Proc Natl Acad Sci U S A 2010;107:16697-702.
51. Gegelashvili G, Civenni G, Racagni G, Danbolt NC, Schousboe I, Schousboe A. Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. Neuroreport 1996;8:261-5. (Pubitemid 126785570)
52. Georgiev D, Taniura H, Kambe Y, Takarada T, Yoneda Y. A critical importance of polyamine site in NMDA receptors for neurite outgrowth and fasciculation at early stages of P19 neuronal differentiation. Exp Cell Res 2008;314:2603-17.
53. Gould E, Reeves AJ, Graziano MS, Gross CG. Neurogenesis in the neocortex of adult primates. Science 1999;286:548-52.
54. Greenberg DS, Toiber D, Berson A, Soreq H. Acetylcholinesterase variants in Alzheimer's disease: from neuroprotection to programmed cell death. Neurodegener Dis 2010;7:60-3.
55. Gregor P, O'Hara BF, Yang X, Uhl GR. Expression and novel subunit isoforms of glutamate receptor genes GluR5 and GluR6. Neuroreport 1993;4:1343-6. (Pubitemid 23297985)
56. Gregory ML, Guzauskas GF, Edgar TS, Clarkson KB, Srivastava AK, Holden KR. A novel GLRA1 mutation associated with an atypical hyperekplexia phenotype. J Child Neurol 2008;23:1433-8.
57. Groc L, Gustafsson B, Hanse E. AMPA signalling in nascent glutamatergic synapses: there and not there! Trends Neurosci 2006;29:132-9.
58. Gupta AR, State MW. Recent advances in the genetics of autism. Biol Psychiatry 2007;61:429-37. (Pubitemid 46185337)
59. Haydon PG, McCobb DP, Kater SB. The regulation of neurite outgrowth, growth cone motility, and electrical synaptogenesis by serotonin. J Neurobiol 1987;18:197-215. (Pubitemid 17028471)
60. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001;65:21-37. (Pubitemid 32743368)
61. Hoehn-Saric R, McLeod DR, Glowa JR. The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response. Biol Psychiatry 1991;30:170-6.
62. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A 2002;99:7746-50. (Pubitemid 34568762)
63. Huettner JE. Kainate receptors and synaptic transmission. Prog Neurobiol 2003;70:387-407. (Pubitemid 37159280)
64. IMGSAC IMGSoAC. Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet 2001;10:973-82.
65. Jacob S, Brune CW, Badner JA, Ernstrom K, Courchesne E, Lord C, et al. Family-based association testing of glutamate transporter genes in autism. Psychiatr Genet 2010; [Epub ahead of print]. doi:10.1097/YPG.0b013e328341a323.
66. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002;7:302-10. (Pubitemid 34280638)
67. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27-9. (Pubitemid 36548785)
68. Johnston MV. Neurotransmitters and vulnerability of the developing brain. Brain Dev 1995;17:301-6.
69. Jones MB, Szatmari P. A risk-factor model of epistatic interaction, focusing on autism. Am J Med Genet 2002;114:558-65. (Pubitemid 34680585)
70. Karler R, Chaudhry IA, Calder LD, Turkanis SA. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res 1990;537:76-82.
71. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003;25:377-82. (Pubitemid 36957865)
72. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005;179:4-29. (Pubitemid 40576690)
73. Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 2010; [Epub ahead of print]. doi:10.1002/jcp.22609.
74. Komuro H, Rakic P. Modulation of neuronal migration by NMDA receptors. Science 1993;260:95-7. (Pubitemid 23122752)
75. Kwong WH, Chan WY, Lee KK, Fan M, Yew DT. Neurotransmitters, neuropeptides and calcium binding proteins in developing human cerebellum: a review. Histochem J 2000;32:521-34.
76. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006;27:254-89.
77. Lamb JA, Barnby G, Bonora E, Sykes N, Bacchelli E, Blasi F, et al. Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet 2005;42:132-7. (Pubitemid 40204367)
78. Lasorsa FM, Pinton P, Palmieri L, Fiermonte G, Rizzuto R, Palmieri F. Recombinant expression of the Ca(2+)-sensitive aspartate/glutamate carrier increases mitochondrial ATP production in agonist-stimulated Chinese hamster ovary cells. J Biol Chem 2003;278:38686-92. (Pubitemid 37221765)
79. Lauriat TL, Richler E, McInnes LA. A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease. Neurochem Int 2007;50:271-80. (Pubitemid 44879685)
80. Lazoff T, Zhong L, Piperni T, Fombonne E. Prevalence of pervasive developmental disorders among children at the English Montreal School Board. Can J Psychiatry 2010;55:715-20.
81. Li H, Li Y, Shao J, Li R, Qin Y, Xie C, et al. The association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2008;147B:194-200. (Pubitemid 351355280)
82. Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001;69:327-40. (Pubitemid 32695205)
83. Macnab LT, Williams SM, Pow DV. Expression of the exon 3 skipping form of GLAST, GLAST1a, in brain and retina. Neuroreport 2006;17:1867-70. (Pubitemid 46006288)
84. Malenka RC, Nicoll RA. Long-term potentiation - a decade of progress? Science 1999;285:1870-4.
85. Malherbe P, Kratzeisen C, Lundstrom K, Richards JG, Faull RL, Mutel V. Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Brain Res Mol Brain Res 1999;67:201-10. (Pubitemid 29193176)
86. Manent JB, Demarque M, Jorquera I, Pellegrino C, Ben-Ari Y, Aniksztejn L, et al. A noncanonical release of GABA and glutamate modulates neuronal migration. J Neurosci 2005;25:4755-65. (Pubitemid 40664124)
87. Manent JB, Represa A. Neurotransmitters and brainmaturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist 2007;13:268-79. (Pubitemid 46801760)
88. Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis 2004;15:461-73. (Pubitemid 38429961)
89. +-dependent glutamate transporter EAAT4 is expressed throughout the rat fore- and midbrain. J Comp Neurol 2008;511:155-72.
90. Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci 2008;1144:97-112.
91. Mejias R, Adamczyk A, Anggono V, Niranjan T, Thomas GM, Sharma K, et al. Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism. Proc Natl Acad Sci U S A 2011;108:4920-5.
92. Moldrich RX, Jeffrey M, Talebi A, Beart PM, Chapman AG, Meldrum BS. Anti-epileptic activity of group II metabotropic glutamate receptor agonists (--)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (--)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795). Neuropharmacology 2001;41:8-18. (Pubitemid 32607640)
93. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 1989;29:365-402. (Pubitemid 19107360)
94. Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37:489-97. (Pubitemid 30428234)
95. Moriyama Y, Omote H. Vesicular glutamate transporter acts as a metabolic regulator. Biol Pharm Bull 2008;31:1844-6.
96. Muehlmann AM, Devine DP. Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour. Behav Brain Res 2008;189:32-40.
97. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004;113:e472-86.
98. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, et al. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 1998;392:601-5. (Pubitemid 28207716)
99. Nicoletti F, Bockaert J, Collingridge GL, Conn JP, Ferraguti F, Schoepp DD, et al. Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 2011;60(7-8):1017-41.
100. Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, et al. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:677-85. (Pubitemid 38987392)
101. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998;54:581-618. (Pubitemid 28123327)
102. Palmieri L, Papaleo V, Porcelli V, Scarcia P, Gaita L, Sacco R, et al. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry 2010;15:38-52.
103. Palmieri L, Pardo B, Lasorsa FM, del Arco A, Kobayashi K, Iijima M, et al. Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J 2001;20:5060-9. (Pubitemid 32910902)
104. Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 1999;8:805-12.
105. Pickles A, Bolton P, Macdonald H, Bailey A, Le Couteur A, Sim CH, et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 1995;57:717-26.
106. Pickles A, Starr E, Kazak S, Bolton P, Papanikolaou K, Bailey A, et al. Variable expression of the autism broader phenotype: findings from extended pedigrees. J Child Psychol Psychiatry 2000;41:491-502. (Pubitemid 30311527)
107. Pin JP, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995;34:1-26.
108. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, et al. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992;360:464-7.
109. Pinheiro P, Mulle C. Kainate receptors. Cell Tissue Res 2006;326:457-82. (Pubitemid 44444793)
110. Pow DV, Barnett NL. Developmental expression of excitatory amino acid transporter 5: a photoreceptor and bipolar cell glutamate transporter in rat retina. Neurosci Lett 2000;280:21-4. (Pubitemid 30069564)
111. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001;57:1618-28. (Pubitemid 33055480)
112. Rabionet R, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, Haines JL, et al. Analysis of the autism chromosome 2 linkage region: GAD1 and other candidate genes. Neurosci Lett 2004;372:209-14. (Pubitemid 39470198)
113. Rabionet R, McCauley JL, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, et al. Lack of association between autism and SLC25A12. Am J Psychiatry 2006;163:929-31. (Pubitemid 44464545)
114. Ramanathan S, Woodroffe A, Flodman PL, Mays LZ, Hanouni M, Modahl CB, et al. A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R. BMC Med Genet 2004;5:10.
115. +-regulated mitochondrial aspartateglutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Res Dev Brain Res 2003;143:33-46.
116. Ramoz N, Cai G, Reichert JG, Silverman JM, Buxbaum JD. An analysis of candidate autism loci on chromosome 2q24-q33: evidence for association to the STK39 gene. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1152-8.
117. Ramoz N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL, et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 2004;161:662-9. (Pubitemid 38445510)
118. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998;43:7-14. (Pubitemid 28124643)
119. Rapin I, Tuchman RF. Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin North Am 2008;55:1129-46. viii.
120. Raymond GV, Bauman ML, Kemper TL. Hippocampus in autism: a Golgi analysis. Acta Neuropathol 1996;91:117-9.
121. Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 1999;46:1219-33. (Pubitemid 30114439)
122. Richards G, Messer J, Faull RL, Stadler H, Wichmann J, Huguenin P, et al. Altered distribution of mGlu2 receptors in beta-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice. Brain Res 2010;1363:180-90.
123. Rinaldi T, Kulangara K, Antoniello K, Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A 2007;104:13501-6. (Pubitemid 47293974)
124. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 1993;87:312-6. (Pubitemid 23134638)
125. Rose EM, Koo JC, Antflick JE, Ahmed SM, Angers S, Hampson DR. Glutamate transporter coupling to Na, K-ATPase. J Neurosci 2009;29:8143-55.
126. Sakurai T, Ramoz N, Barreto M, Gazdoiu M, Takahashi N, Gertner M, et al. Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry 2010;67:887-94.
127. Schultz RT, Klin A. Genetics of childhood disorders: XLIII. Autism, part 2: neural foundations. J Am Acad Child Adolesc Psychiatry 2002;41:1259-62. (Pubitemid 38338048)
128. Segurado R, Conroy J, Meally E, Fitzgerald M, Gill M, Gallagher L. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry 2005;162:2182-4. (Pubitemid 41598278)
129. Serajee FJ, Zhong H, Nabi R, Huq AH. Themetabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 2003;40:e42.
130. Shah S, Apuya J, Gopalakrishnan S, Martin T. Combination of oral ketamine and midazolam as a premedication for a severely autistic and combative patient. J Anesth 2009;23:126-8.
131. Shao Y, Wolpert CM, Raiford KL, Menold MM, Donnelly SL, Ravan SA, et al. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 2002;114:99-105.
132. Shinohe A, Hashimoto K, Nakamura K, Tsujii M, Iwata Y, Tsuchiya KJ, et al. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1472-7. (Pubitemid 44634960)
133. Shuang M, Liu J, Jia MX, Yang JZ, Wu SP, Gong XH, et al. Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. Am J Med Genet B Neuropsychiatr Genet 2004;131B:48-50. (Pubitemid 39458437)
134. SidAhmed-Mezi M, Pumain R, Louvel J, Sokoloff P, Laschet J. New therapeutic targets to develop molecules active in drug-resistant epilepsies. Epilepsia 2010;51(Suppl 3):43-7.
135. Silverman JL, Tolu SS, Barkan CL, Crawley JN. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 2010;35:976-89.
136. Silverman JM, Buxbaum JD, Ramoz N, Schmeidler J, Reichenberg A, Hollander E, et al. Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphism. Am J Med Genet B Neuropsychiatr Genet 2008;147:408-10. (Pubitemid 351536809)
137. Spence RD, Zhen Y, White S, Schlinger BA, Day LB. Recovery of motor and cognitive function after cerebellar lesions in a songbird: role of estrogens. Eur J Neurosci 2009;29:1225-34.
138. Storck T, Schulte S, Hofmann K, Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci U S A 1992;89:10955-9.
139. Takayasu Y, Iino M, Takatsuru Y, Tanaka K, Ozawa S. Functions of glutamate transporters in cerebellar Purkinje cell synapses. Acta Physiol (Oxf) 2009;197:1-12.
140. Tanaka H, Grooms SY, Bennett MV, Zukin RS. The AMPAR subunit GluR2: still front and center-stage. Brain Res 2000;886:190-207.
141. Tanaka K. Role of glutamate transporters in the pathophysiology of major mental illnesses. Nihon Shinkei Seishin Yakurigaku Zasshi 2009;29:161-4.
142. van Praag H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional neurogenesis in the adult hippocampus. Nature 2002;415:1030-4. (Pubitemid 34193451)
143. Vincent JB, Kolozsvari D, Roberts WS, Bolton PF, Gurling HM, Scherer SW. Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. Am J Med Genet B Neuropsychiatr Genet 2004;129B:82-4. (Pubitemid 38989074)
144. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009;461:802-8.
145. Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science 2006;313:1093-7. (Pubitemid 44300229)
146. Wijetunge LS, Till SM, Gillingwater TH, Ingham CA, Kind PC. mGluR5 regulates glutamate-dependent development of the mouse somatosensory cortex. J Neurosci 2008;28:13028-37.
147. Yip J, Soghomonian JJ, Blatt GJ. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol 2007;113:559-68. (Pubitemid 46672602)
148. Yip J, Soghomonian JJ, Blatt GJ. Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study. Autism Res 2009;2:50-9.
149. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003;73:886-97. (Pubitemid 37271891)